Governor McCrory Celebrates Groundbreaking for International Medical Manufacturer in Durham

Press Release

Governor Pat McCrory joined employees, executives and elected officials this morning to celebrate the groundbreaking of bioMérieux's new 25,500 square-foot facility in Durham. This addition to the company's existing Durham facility will help create more than 44 new jobs and allow bioMérieux to better meet the increasing global demand for detection and identification of bloodborne infections such as sepsis. The company currently employs more than 630 people at its Durham facility.

The company manufactures products for diagnosing infectious diseases and cancer screening. Their products are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products.

"With headquarters in France and operations in more than 150 countries, bioMérieux could have chosen anywhere in the world for its distribution system hub," said Governor McCrory. "But the global company chose to expand its operations in North Carolina, which is more evidence that our skilled workforce can compete on a global stage. By continuing to improve North Carolina's education and economic climate, we believe bioMérieux and companies from around the world will continue to come to our state and thrive."

Prior to addressing employees and participating in the groundbreaking ceremony, the governor toured bioMérieux's Durham facility and construction site.

In January 2013, Governor McCrory and Commerce Secretary Sharon Decker announced that the global manufacturer of patient health diagnostics solutions headquartered in France planned to create jobs, invest $48.3 million in Durham and expand its North Carolina presence.

Governor McCrory thanked the partners that helped with this project, including the North Carolina Department of Commerce, North Carolina Community Colleges, Durham County, North Carolina Biotech Center and the Greater Durham Chamber of Commerce.

A world leader in the field of in vitro diagnostics for 50 years, bioMérieux is present in more than 150 countries through 41 subsidiaries and a large network of distributors. In 2013, revenues reached $2.2 billion with 87 percent of sales outside of France. bioMérieux provides diagnostic solutions (reagents, instruments, software) which determine the source of disease and contamination to improve patient health and ensure consumer safety. For more information about bioMerieux, including job opportunities, go to www.biomerieux-usa.com.

Source